NURYLBO
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Mar 2023)
What this means for you
This application is over — abandoned 27 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88579099
- Mark type
- Stylized text
- Filed
- 14 Aug 2019
- Published for opposition
- 24 Dec 2019
- Abandoned
- 27 Mar 2023
- Attorney of record
- Jeffrey S.Steen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of developmental disorders; Pharmaceutical preparations for the treatment of neurological disorders
Owner
- Ovid Therapeutics Inc., New York, NY, US
- Ovid Therapeutics Inc., New York, NY, US
Prosecution history
- 27 Mar 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 27 Mar 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2022 — SOU EXTENSION 5 GRANTED
- 08 Aug 2022 — SOU EXTENSION 5 FILED
- 16 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 09 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Feb 2022 — SOU EXTENSION 4 GRANTED
- 07 Feb 2022 — SOU EXTENSION 4 FILED
- 07 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 14 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2021 — SOU EXTENSION 3 GRANTED
- 12 Aug 2021 — SOU EXTENSION 3 FILED
- 12 Aug 2021 — SOU TEAS EXTENSION RECEIVED